5-Lipoxygenase Inhibitors: Bones, Cardio, and Cancer
AREAS COVERED IN THIS REVIEW: We first summarize the biochemical regulation of 5-LO and the general pharmacological concepts in 5-LO inhibition by currently available compounds, and subsequently we report recent developments deduced from recent scientific publications and patents.
WHAT THE READER WILL GAIN: A comprehensive overview about the different molecular pharmacological strategies to inhibit 5-LO and the most successful previous 5-LO inhibitors. The review also gives insights into novel concepts, for example, dual prostaglandin/LT synthesis inhibition and reveals novel compounds patented or developed within the past 5 years.
TAKE HOME MESSAGE: Despite the increasing therapeutic indications of anti-LT therapy, the progress in the development of novel 5-LO inhibitors is moderate. However, novel molecular concepts in the intervention with LT biosynthesis seem promising.
Pergola C, Werz O.
5-Lipoxygenase inhibitors: a review of recent developments and patents.
Expert Opin Ther Pat.
Eberhard-Karls-University Tuebingen, Pharmaceutical Institute, Department of Pharmaceutical Analytics, Auf der Morgenstelle 8, 72076 Tuebingen, Germany.